Groundbreaking results for new atrial fibrillation medication
A new anticoagulant agent is more effective and safer than warfarin in preventing stroke in atrial fibrillation (AF) patients. This is one finding of an extensive international clinical study, RE-LY, led by the Uppsala Clinical Research Center (UCR) at Uppsala University and Uppsala University Hospital.